Pharmaceuticals - Mauritius

Mauritius

In 2024, the revenue in the Pharmaceuticals market of Mauritius is estimated to reach US$82.36m.
The largest market within this industry is Oncology Drugs, which is projected to have a market volume of US$15.24m in 2024.
It is expected that the revenue will grow at an annual rate of 7.33% from 2024 to 2028, resulting in a market volume of US$109.30m by 2028.
When compared globally, United States is expected to generate the highest revenue, amounting to US$636.90bn in 2024.
Mauritius is emerging as a hub for pharmaceutical manufacturing due to its favorable business environment and strategic location.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Mauritius has been experiencing steady growth in recent years.

Customer preferences: Mauritius has a growing population with increasing healthcare needs, thus contributing to the growth of the pharmaceuticals market. Customers in Mauritius are becoming more health-conscious and are seeking better quality products. They are also looking for affordable healthcare solutions, which has led to an increase in demand for generic drugs.

Trends in the market: The pharmaceuticals market in Mauritius is dominated by imported drugs, with India being the largest supplier. The market is highly competitive, with many local and international players. There is a growing trend towards the use of herbal and natural remedies, which has led to an increase in demand for traditional medicines. Moreover, there has been a shift towards the use of e-pharmacies, which has made it easier for customers to access medicines.

Local special circumstances: The government of Mauritius has been taking steps to improve healthcare in the country, which has led to an increase in demand for pharmaceuticals. The government has been investing in healthcare infrastructure and has been working towards improving access to healthcare for all citizens. Additionally, the country has a well-established regulatory framework for the pharmaceuticals industry, which ensures that only safe and effective drugs are available in the market.

Underlying macroeconomic factors: Mauritius has a stable political environment and a well-diversified economy, which has contributed to the growth of the pharmaceuticals market. The country has a strong focus on education and has a well-educated workforce, which has led to the development of a skilled pharmaceuticals industry. Furthermore, Mauritius is strategically located, making it an ideal hub for pharmaceutical companies looking to expand into the African market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.